Live Breaking News & Updates on Commodore Capital

Stay updated with breaking news from Commodore capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada , Wellington , New-zealand-general , New-zealand , Steven-gannon , Sherrington-robin , Capital-international-investors , News-ratings-for-xenon-pharmaceuticals-daily , Wellington-management-group , Citigroup , Royal-bank , Avoro-capital-advisors

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada , Wellington , New-zealand-general , New-zealand , Steven-gannon , Sherrington-robin , Cantor-fitzgerald , Royal-bank , Wellington-management-group , Hedge-funds-weigh-in-on-xenon-pharmaceuticals , Xenon-pharmaceuticals-price-performance , Analyst-recommendations-for-xenon-pharmaceuticals

Pharvaris (NASDAQ:PHVS) Given Overweight Rating at Morgan Stanley

Pharvaris (NASDAQ:PHVS) Given Overweight Rating at Morgan Stanley
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blackstone-inc , Walleye-capital , Pharvaris-company-profile , Morgan-stanley , Vivo-capital , Free-report , Stock-down , Bay-capital-management , Commodore-capital , Get-free-report , Pharvaris-daily

Morgan Stanley Reiterates "Overweight" Rating for Pharvaris (NASDAQ:PHVS)

Pharvaris (NASDAQ:PHVS – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Morgan Stanley in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $34.00 price target on the stock. Morgan Stanley’s price objective indicates a potential upside of 64.65% from the stock’s previous […] ....

Blackstone-inc , Morgan-stanley , Walleye-capital , Bio-partners , Pharvaris-company-profile , Nasdaq , Get-free-report , Bay-capital-management , Commodore-capital , Pharvaris-daily , Pharvaris

Cabaletta Bio (NASDAQ:CABA) Receives "Overweight" Rating from Cantor Fitzgerald

Cabaletta Bio (NASDAQ:CABA) Receives "Overweight" Rating from Cantor Fitzgerald
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Alger , Algeria , Gwendolyn-binder , Blackrock-inc , Cabaletta-bio-inc , Bain-capital-life-sciences-investors , Cantor-fitzgerald , Perceptive-advisors , Fred-alger-management , Wells-fargo-company , Jefferies-financial-group , Citigroup